214 related articles for article (PubMed ID: 26667279)
1. Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease.
Haas LT; Salazar SV; Kostylev MA; Um JW; Kaufman AC; Strittmatter SM
Brain; 2016 Feb; 139(Pt 2):526-46. PubMed ID: 26667279
[TBL] [Abstract][Full Text] [Related]
2. Ca(2+)/calmodulin-dependent protein kinase II interacts with group I metabotropic glutamate and facilitates receptor endocytosis and ERK1/2 signaling: role of β-amyloid.
Raka F; Di Sebastiano AR; Kulhawy SC; Ribeiro FM; Godin CM; Caetano FA; Angers S; Ferguson SS
Mol Brain; 2015 Mar; 8():21. PubMed ID: 25885040
[TBL] [Abstract][Full Text] [Related]
3. Neuronal transcriptome, tau and synapse loss in Alzheimer's knock-in mice require prion protein.
Stoner A; Fu L; Nicholson L; Zheng C; Toyonaga T; Spurrier J; Laird W; Cai Z; Strittmatter SM
Alzheimers Res Ther; 2023 Nov; 15(1):201. PubMed ID: 37968719
[TBL] [Abstract][Full Text] [Related]
4. Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.
Brody AH; Strittmatter SM
Adv Pharmacol; 2018; 82():293-323. PubMed ID: 29413525
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity.
Goniotaki D; Lakkaraju AKK; Shrivastava AN; Bakirci P; Sorce S; Senatore A; Marpakwar R; Hornemann S; Gasparini F; Triller A; Aguzzi A
PLoS Pathog; 2017 Nov; 13(11):e1006733. PubMed ID: 29176838
[TBL] [Abstract][Full Text] [Related]
6. Characterizing affinity epitopes between prion protein and β-amyloid using an epitope mapping immunoassay.
Kang M; Kim SY; An SS; Ju YR
Exp Mol Med; 2013 Aug; 45(8):e34. PubMed ID: 23907583
[TBL] [Abstract][Full Text] [Related]
7. Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists.
Gunther EC; Smith LM; Kostylev MA; Cox TO; Kaufman AC; Lee S; Folta-Stogniew E; Maynard GD; Um JW; Stagi M; Heiss JK; Stoner A; Noble GP; Takahashi H; Haas LT; Schneekloth JS; Merkel J; Teran C; Naderi ZK; Supattapone S; Strittmatter SM
Cell Rep; 2019 Jan; 26(1):145-158.e8. PubMed ID: 30605671
[TBL] [Abstract][Full Text] [Related]
8. Prion Protein as a Toxic Acceptor of Amyloid-β Oligomers.
Purro SA; Nicoll AJ; Collinge J
Biol Psychiatry; 2018 Feb; 83(4):358-368. PubMed ID: 29331212
[TBL] [Abstract][Full Text] [Related]
9. Nonsense mutation in PRNP associated with clinical Alzheimer's disease.
Guerreiro R; Brás J; Wojtas A; Rademakers R; Hardy J; Graff-Radford N
Neurobiol Aging; 2014 Nov; 35(11):2656.e13-2656.e16. PubMed ID: 24958194
[TBL] [Abstract][Full Text] [Related]
10. The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer's Disease.
de Lima IBQ; Ribeiro FM
Curr Neuropharmacol; 2023; 21(2):164-182. PubMed ID: 34951388
[TBL] [Abstract][Full Text] [Related]
11. Dual role of cellular prion protein in normal host and Alzheimer's disease.
Onodera T
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(4):155-173. PubMed ID: 28413194
[TBL] [Abstract][Full Text] [Related]
12. Amino Acid Transporters Proteins Involved in the Glutamate-Glutamine Cycle and Their Alterations in Murine Models of Alzheimer's Disease.
Vázquez-Durán DL; Ortega A; Rodríguez A
Mol Neurobiol; 2024 Jan; ():. PubMed ID: 38273046
[TBL] [Abstract][Full Text] [Related]
13. Clarifying the role of D1 receptor signalling in Alzheimer's-related epilepsy commentary on Szabo et al. (2024).
D'Amelio M; Costa C
Eur J Neurosci; 2024 May; 59(10):2549-2551. PubMed ID: 38648886
[No Abstract] [Full Text] [Related]
14. Seeking a New Paradigm for Alzheimer's Disease: Considering the Roles of Inflammation, Blood-Brain Barrier Dysfunction, and Prion Disease.
McCaulley ME; Grush KA
Int J Alzheimers Dis; 2017; 2017():2438901. PubMed ID: 29359063
[TBL] [Abstract][Full Text] [Related]
15. Editorial - FAU research on Alzheimer's disease.
Fields GB
J Cell Physiol; 2024 Jun; 239(6):e31316. PubMed ID: 38747507
[No Abstract] [Full Text] [Related]
16. Mapping the mediators of Alzheimer's disease.
O'Leary K
Nat Med; 2022 Feb; ():. PubMed ID: 35228699
[No Abstract] [Full Text] [Related]
17. Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease.
Haas LT; Strittmatter SM
J Biol Chem; 2016 Aug; 291(33):17112-21. PubMed ID: 27325698
[TBL] [Abstract][Full Text] [Related]
18. Cellular prion protein as a receptor for amyloid-β oligomers in Alzheimer's disease.
Salazar SV; Strittmatter SM
Biochem Biophys Res Commun; 2017 Feb; 483(4):1143-1147. PubMed ID: 27639648
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-β Receptors: The Good, the Bad, and the Prion Protein.
Jarosz-Griffiths HH; Noble E; Rushworth JV; Hooper NM
J Biol Chem; 2016 Feb; 291(7):3174-83. PubMed ID: 26719327
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
